1. Home
  2. RCKT vs BV Comparison

RCKT vs BV Comparison

Compare RCKT & BV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • BV
  • Stock Information
  • Founded
  • RCKT 1999
  • BV 1939
  • Country
  • RCKT United States
  • BV United States
  • Employees
  • RCKT N/A
  • BV N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • BV Business Services
  • Sector
  • RCKT Health Care
  • BV Consumer Discretionary
  • Exchange
  • RCKT Nasdaq
  • BV Nasdaq
  • Market Cap
  • RCKT 764.5M
  • BV 1.3B
  • IPO Year
  • RCKT N/A
  • BV 2018
  • Fundamental
  • Price
  • RCKT $7.18
  • BV $15.76
  • Analyst Decision
  • RCKT Strong Buy
  • BV Buy
  • Analyst Count
  • RCKT 10
  • BV 8
  • Target Price
  • RCKT $44.10
  • BV $17.41
  • AVG Volume (30 Days)
  • RCKT 3.2M
  • BV 602.4K
  • Earning Date
  • RCKT 05-08-2025
  • BV 05-07-2025
  • Dividend Yield
  • RCKT N/A
  • BV N/A
  • EPS Growth
  • RCKT N/A
  • BV N/A
  • EPS
  • RCKT N/A
  • BV 0.07
  • Revenue
  • RCKT N/A
  • BV $2,729,300,000.00
  • Revenue This Year
  • RCKT N/A
  • BV $3.29
  • Revenue Next Year
  • RCKT N/A
  • BV $3.67
  • P/E Ratio
  • RCKT N/A
  • BV $214.17
  • Revenue Growth
  • RCKT N/A
  • BV N/A
  • 52 Week Low
  • RCKT $4.55
  • BV $11.24
  • 52 Week High
  • RCKT $26.98
  • BV $18.89
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 46.92
  • BV 75.78
  • Support Level
  • RCKT $6.21
  • BV $14.11
  • Resistance Level
  • RCKT $8.26
  • BV $14.63
  • Average True Range (ATR)
  • RCKT 0.58
  • BV 0.47
  • MACD
  • RCKT 0.03
  • BV 0.18
  • Stochastic Oscillator
  • RCKT 28.05
  • BV 78.21

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About BV BrightView Holdings Inc.

BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.

Share on Social Networks: